Home > Balance Sheet > INDO US BIOTECH

INDO US BIOTECH
Contingent Liabilities

    Back to Balance Sheet
INDO US BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results

INDO US BIOTECH Last 5 Year Contingent Liabilities History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
Contingent Liabilities ₹2.91 Cr₹1.17 Cr₹0.98 Cr₹0.95 Cr₹0.67 Cr

What is the latest Contingent Liabilities ratio of INDO US BIOTECH ?

The latest Contingent Liabilities ratio of INDO US BIOTECH is ₹2.91 Cr based on Mar2026 Standalone results.
Year Contingent Liabilities
Mar2026₹2.91 Cr
Mar2025₹1.17 Cr
Mar2024₹0.98 Cr
Mar2023₹0.95 Cr
Mar2022₹0.67 Cr

How is Contingent Liabilities of INDO US BIOTECH Trending?

Years Contingent Liabilities % Change
Mar2026 ₹2.91 Cr
148.68
Mar2025 ₹1.17 Cr
19.86
Mar2024 ₹0.98 Cr
2.84
Mar2023 ₹0.95 Cr
42.64
Mar2022 ₹0.67 Cr -

Compare Contingent Liabilities of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹127.6 Cr -13.1% -17.6% -47.5% Stock Analytics
KAVERI SEED COMPANY ₹3,763.8 Cr 0% 4.5% -30.8% Stock Analytics
VENKYS (INDIA) ₹2,230.8 Cr -6.9% -5.4% 11.3% Stock Analytics
AVT NATURAL PRODUCTS ₹1,340.7 Cr -12.8% -10.5% 28.8% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹870.7 Cr -12.7% -1.4% NA Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹560.9 Cr -0.2% 9.7% 11.3% Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

-13.1%

-17.6%

-47.5%

SENSEX

-1.6%

-2.3%

-11.5%


You may also like the below Video Courses